Literature DB >> 6881242

A retrospective review of 26 cases of dysthyroid optic neuropathy.

G J Panzo, R L Tomsak.   

Abstract

Sixteen patients (14 women and two men) with dysthyroid optic neuropathy (26 involved eyes) were treated with either oral corticosteroids, orbital irradiation, surgical orbital decompression, combined corticosteroids and irradiation, or combined corticosteroids and surgical decompression. Thirteen of 16 eyes responded favorably to corticosteroid therapy but eight of the 13 relapsed upon discontinuation of treatment. Two of four eyes responded to irradiation initially but later relapsed. The response to orbital decompression was almost uniformly beneficial (eight of nine eyes responded) and lasting in all. Combined modes of therapy offered no additional advantage.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6881242     DOI: 10.1016/s0002-9394(14)77786-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

Authors:  K A Ponto; T Diana; H Binder; N Matheis; S Pitz; N Pfeiffer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

2.  Radiotherapy of severe ophthalmic Graves' disease.

Authors:  B M van Ouwerkerk; R Wijngaarde; G Hennemann; J G van Andel; E P Krenning
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

3.  Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.

Authors:  Mário L R Monteiro; Rodrigo B S Moritz; Hélio Angotti Neto; Joseph E Benabou
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

4.  The value of visual evoked potentials in optic neuropathy of Graves' disease.

Authors:  K Setälä; C Raitta; M Välimäki; V Katevuo; B A Lamberg
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

5.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

6.  [Management of moderate and severe dysthyroid orbitopathy: about 22 cases].

Authors:  Nadia Daldoul; Leila Knani; Faten Gatfaoui; Hechmi Mahjoub
Journal:  Pan Afr Med J       Date:  2017-08-07

7.  Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.

Authors:  Connie M Sears; Yao Wang; Lucy A Bailey; Roger Turbin; Prem S Subramanian; Raymond Douglas; Kimberly Cockerham; Andrea L Kossler
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.